Actym Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-05-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.actymthera.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
- First Posted Date
- 2024-03-28
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Actym Therapeutics, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT06336148
- Locations
- 🇺🇸
University of Southern California Norris Comprehensive Cancer Center, 1441 Eastlake Ave., Los Angeles, California, United States
🇺🇸UPMC Hillman Cancer Center, 5115 Centre Ave, Pittsburgh, Pennsylvania, United States
🇦🇺Westmead Hospital, Cnr Hawkesbury Road and Darcy Road, Site No: 200, Westmead, New South Wales, Australia
News
No news found